Colony Group LLC Repligen Corp Transaction History

Colony Group LLC

  • $6.66 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$247.59 - $304.47 $273,834 - $336,743
-1,106 Closed
0 $0
Q3 2021

Nov 17, 2021
BUY
$194.77 - $324.21 $215,415 - $358,576
1,106 New
1,106 $320,000
Q1 2020

May 18, 2020
SELL
$84.96 - $109.14 $198,466 - $254,951
-2,336 Closed
0 $0
Q4 2019

Feb 18, 2020
BUY
$73.84 - $93.08 $172,490 - $217,434
2,336 New
2,336 $216,000

Others Institutions Holding RGEN

# of Institutions
486
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email